Repertoire Immune Medicines
Repertoire Immune Medicines is seeking a Scientist II to join its autoimmune tolerance induction team, focusing on the design, development, and optimization of mRNA constructs for therapeutic applications. The role involves collaborating with cross-functional teams to advance drug candidates from concept through preclinical and clinical development stages. The position requires expertise in mRNA production, purification, and characterization to support the company's innovative immune therapies.
Headquarters
Cambridge, Massachusetts, United States
Company Size
51-200 employees
Founded
2020
Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the power of the human immune system to prevent or treat cancer and autoimmune diseases. The company's proprietary DECODE platform decodes the immune synapse and T cell repertoire to discover the codes used to program the body's immune response against disease. Repertoire leverages these insights to design and develop targeted, programmable immune medicines for patients with cancer and autoimmune conditions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Repertoire Immune Medicines.